Cardiologic safety of menopausal hormone therapies;Bezpieczeństwo kardiologiczne terapii hormonalnych okresu menopauzy

Przeglad Menopauzalny

Volumn 13, Issue 6, 2009, Pages 315-319

  Stachowiak, Grzegorz ^a   Pertyński, Tomasz ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Cardiovascular diseases; Hormonal therapy; Menopause; Progestins

Indexed keywords

GESTAGEN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; VENOUS THROMBOEMBOLISM;

EID: 76549106287     PISSN: 16438876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Pertyński T. Kobieta w wieku okołomenopauzalnym i pomenopauzalnym. Medycyna po Dyplomie 1997; 6: 13-9.
2. Rossi R, Origliani G, Modena MG. Transdermal 17-beta-estradiol and risk of developing type 2 diabetes in population of healthy, nonobese postmenopausal women. Diabetes Care 2004; 27: 645-9.
3. Nilsen J, Mor G, Naftolin F. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J Neurobiol 2000; 43: 64-78.
4. Grodstein F, Stampfer MJ, Goldhaber SZ, et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983-7.
5. Gutthann SP, Rodriguez LAG, Castellsague J, et al. Hormone replacement therapy and risk of venous thromboembolism: population based casecontrol study. Br Med J 1997; 314: 796-800.
6. Grodstein F, Manson JE, Colditz GA, et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133: 933-41.
7. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of oestrogen replacement on the progression on the coronary-artery atherosclerosis. N Engl J Med 2000; 343: 522-9.
8. Viscoli CM, Brass LM, Kerman WN, et al. A clinical trial of estrogen-replacement therapy after ischaemic stroke. N Engl J Med 2001; 325: 1243-9.
9. Rekomendacje Zarza̧du Głównego PTG w sprawie stosowania terapii hormonalnej wieku menopauzalnego Ginekologia po Dyplomie Wrzesień 2006; 19-20.
10. Collins P, Rosano G, Casey C, et al. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists. Eur Heart J 2007; 28: 2028-40.
11. Pertyński T, Stachowiak G. Wybór drogi podania w terapii hormonalnej okresu menopauzy - kiedy warto zamienić tabletki na plastry? Przegla̧d Menopauzalny 2006; 5: 323-8.
12. Canonico M, Plu-Bureau G, Lowe GD, et al. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 2008; 36: 1227-31.
13. Lowe GD, Upton MN, Rumley A, et al. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein - a cross-sectional population survey. Thromb Haemost 2001; 86: 550-6.
14. Grodstein F, Manson JE, Stampfer MJ, et al. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med 2008; 168: 861-6.
15. Pertyński T, Stachowiak G. Niskie dawki w terapii hormonalnej okresu menopauzy. Przegla̧d Menopauzalny 2006; 4: 223-7.
16. Collins P, Flather M, Lees B, et al. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study. Eur Heart J 2006; 27: 2046-53.
17. Sitruk-Ware R. Pharmacological profile of progestins. Maturitas 2008; 61: 151-7.
18. Schindler AE. Differential effects of progestins on hemostasis. Maturitas 2003; 46 (Suppl 1): S31-7
19. Sitruk-Ware R. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation. Climacteric 2007; 10: 358-70.
20. Seeger H, Wallwiener D, Mueck AO. Effects of drospirenone on cardiovascular markers in human aortic endothelial cells. Climacteric 2009; 12: 80-7.
21. Pertyński T, Stachowiak G. Nadciśnienie tȩtnicze u kobiet w okresie menopauzy. Prz Menopauz 2008; 2: 96-101.
22. Schmeider C, et al. 8th European Congress on Menopause (EMAS) - London, May 16-20 2009 [in print].
23. The Writing Group on behalf of the Workshop Consensus Group. Aging, menopause, cardiovascular disease and HRT. Climacteric 2009; 12: 368-77.